AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 104 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $605,000 | -19.7% | 26,833 | -16.7% | 0.03% | -42.3% |
| Q1 2016 | $753,000 | -38.7% | 32,195 | +4.2% | 0.05% | -29.7% |
| Q3 2015 | $1,228,000 | -16.6% | 30,905 | +44.9% | 0.07% | -10.8% |
| Q2 2015 | $1,473,000 | -15.5% | 21,335 | -33.1% | 0.08% | -22.4% |
| Q1 2015 | $1,743,000 | +597.2% | 31,889 | +209.9% | 0.11% | +234.4% |
| Q4 2013 | $250,000 | – | 10,289 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
| Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
| Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
| Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
| FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
| AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
| Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |